Correlation Between Soleno Therapeutics and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Soleno Therapeutics and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Soleno Therapeutics and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Soleno Therapeutics and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Soleno Therapeutics and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Soleno Therapeutics with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Soleno Therapeutics and Tarsus Pharmaceuticals.
Diversification Opportunities for Soleno Therapeutics and Tarsus Pharmaceuticals
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Soleno and Tarsus is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Soleno Therapeutics and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Soleno Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Soleno Therapeutics are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Soleno Therapeutics i.e., Soleno Therapeutics and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Soleno Therapeutics and Tarsus Pharmaceuticals
Given the investment horizon of 90 days Soleno Therapeutics is expected to generate 6.0 times more return on investment than Tarsus Pharmaceuticals. However, Soleno Therapeutics is 6.0 times more volatile than Tarsus Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about 0.07 per unit of risk. If you would invest 99.00 in Soleno Therapeutics on August 27, 2024 and sell it today you would earn a total of 5,679 from holding Soleno Therapeutics or generate 5736.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Soleno Therapeutics vs. Tarsus Pharmaceuticals
Performance |
| Timeline |
| Soleno Therapeutics |
| Tarsus Pharmaceuticals |
Soleno Therapeutics and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Soleno Therapeutics and Tarsus Pharmaceuticals
The main advantage of trading using opposite Soleno Therapeutics and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Soleno Therapeutics position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.| Soleno Therapeutics vs. Eliem Therapeutics | Soleno Therapeutics vs. HCW Biologics | Soleno Therapeutics vs. Scpharmaceuticals | Soleno Therapeutics vs. Milestone Pharmaceuticals |
| Tarsus Pharmaceuticals vs. Capricor Therapeutics | Tarsus Pharmaceuticals vs. Soleno Therapeutics | Tarsus Pharmaceuticals vs. Bio Path Holdings | Tarsus Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |